Stay updated on Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial page.

Latest updates to the Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial page
- Check5 days agoChange DetectedThe study plan now includes a new Sample Collection section added on 2026-06-02 as part of revision 3.5.5, superseding revision 3.5.4.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedGainesville site name was updated from University of Florida Health Science Center - Gainesville to UF Health Cancer Institute - Gainesville, and new entries for Diagnostic CAT Scan Service Type and Diagnostic CAT Scan were added to the imaging services.SummaryDifference0.3%

- Check26 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, indicating a small update to the page metadata or formatting; the change does not modify the study details or primary content.SummaryDifference0.0%

- Check41 days agoChange DetectedThe study record now shows Results Posted on 2026-04-29 with updated outcomes (PFS, ORR, OS, adverse events) and provides the Informed Consent Form PDF and Study Protocol/SAP; prior entries like Results Submitted and shorter timeframes have been replaced with the new posted-results status and extended timeframes.SummaryDifference1%

- Check48 days agoChange DetectedThe page’s revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a minor site release rather than a change to the underlying study content.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page revision changed from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Nivolumab in Endometrial Cancer Clinical Trial page.